Consumer Staples·Tobacco·$255.9B
Philip Morris International Inc. (PM) is a leading global tobacco company known for its popular cigarette brands and its commitment to transitioning to smoke-free products....
EPS
Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
Total revenue provides insight into the company's sales performance and market demand.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
8Q
EPS Beat Rate
100%
Avg EPS Surprise
+46.30%
Avg Stock Reaction
+2.65%
In Q1-2026, Philip Morris reported an EPS of $1.96, exceeding expectations by 7.69%. The stock reacted positively, gaining nearly 7% the following day.
Management Promises & Guidance
Analysts are cautiously optimistic about PM's upcoming earnings, with expectations for solid EPS and revenue growth. The company's ability to continue its transition to smoke-free products is a focal point.
Bull Case
If PM can exceed EPS expectations and show strong revenue growth, it may signal successful market adaptation and increased consumer acceptance of its smoke-free products.
Bear Case
Conversely, if the company fails to meet earnings expectations or shows signs of declining sales in traditional products, it could raise concerns about its long-term viability.
EPS
$2.06Earnings per share is a key indicator of the company's profitability and financial health.
Revenue
$10.7BTotal revenue provides insight into the company's sales performance and market demand.
The print will turn on these two things.
Q1
Will EPS exceed the consensus estimate of $2.06?
A beat on EPS could reinforce confidence in PM's profitability and growth strategy, especially in light of its transition to smoke-free products.
Q2
What are the revenue figures compared to the consensus of $10.7B?
Revenue performance will be crucial in assessing demand for PM's products and the effectiveness of its market strategies.
Why consensus could be wrong
The Street may underestimate PM's ability to grow its smoke-free product segment, which could significantly boost overall revenue.
Supporting Evidence
PM's recent product launches have shown promising early sales, suggesting stronger demand than analysts expect.
The company's historical performance indicates a consistent ability to exceed EPS estimates, which may not be fully reflected in current forecasts.
Key Risk
If the revenue from smoke-free products significantly outpaces expectations, it could challenge the current bearish sentiment.
Pre-commit to what would confirm each case.
The upcoming earnings report is pivotal as it will reflect PM's ability to adapt to changing consumer preferences and regulatory pressures.
Bull Confirmed If
An EPS of $2.10 or higher would confirm strong operational performance and market acceptance of new products.
Bear Confirmed If
An EPS below $2.05 would raise concerns about profitability and market challenges.
Implied Move
±20.72%
Historical Avg
±5.7%
The options market is pricing in significant volatility around the earnings report, suggesting investors anticipate a notable reaction.
Options are pricing ±20.7% while PM has averaged ±5.7% over the last 8 prints — setup is pricing rich.
Likely market behavior by outcome — not investment advice.
Beat & Raise
If PM beats expectations, history suggests a potential stock increase of around 2.65%, confirming positive market sentiment.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors digest management's commentary.
Miss
A miss could lead to a decline, with historical patterns indicating a potential drop of around 5.72%.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MEDPACE HLDGS INC
Jul 20, 2026